copyright 1 MG-SEMAGLUTIDE for Dummies
The trial attained equally its Most important endpoints, with semaglutide 2.4 mg demonstrating statistically considerable and outstanding improvements in liver fibrosis without worsening of steatohepatitis, together with resolution of steatohepatitis without any worsening of liver fibrosis in those with MASH in comparison to placebo.oneContact your